Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide. Concomitant therapy of glioblastoma multiforme: Multivariate analysis and other prognostic factors

Journal of Neurosurgical Sciences

Volumn 54, Issue 1, 2010, Pages 7-19

  Birol Sarica, F ^a   Tufan, K ^a   Cekinmez, M ^a   Sen, O ^a   Cem Onal, H ^a   Mertsoylu, H ^a   Topkan, E ^a   Pehlivan, B ^a   Erdogan, B ^a   Nur Altinors, M N ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Glioblastoma; Radiotherapy; Temozolomide

Indexed keywords

TEMOZOLOMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CHILD; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; FOLLOW UP; FRONTAL LOBE; GLIOBLASTOMA; HEADACHE; HISTOPATHOLOGY; HUMAN; LOBECTOMY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PROGNOSIS; REOPERATION; SCHOOL CHILD; TUMOR LOCALIZATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77954755657     PISSN: 00264881     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Burger PC, Green SB. Patient age, histologic features and length of survival in patients with glioblastoma multiforme. Cancer 1991;59:1617-25.
2. Giles GG, Gonzales MF. Epidemiology of brain tumors and factors in prognosis. In: Kaye AH, Laws Jr ER, editors. Brain tumors. 2nd ed. New York, NY: Churchill Livingstone Press; 2001. p. 51-66.
3. Salcman M. Supratentorial gliomas: clinical features and surgical therapy. In: Wilkins RH, Rengachary SS, editors. Neurosurgery. 2nd ed. New York, NY: McGraw Hill; 1996. p. 777-88.
4. Devaux BC, Judith R, O'Fallon JR, Kelly PJ. Resection, biopsy and survival in malignant glial neoplasms a retrospective study of clinical parameter, therapy and outcome. J Neurosurg 1983;78: 767-75.
5. Fadul C, Wood J, Thaler H, Galicich J, Patterson RH, Posner JB. Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology 1988;38:1374-9.
6. Kreth FW, Warnke PC, Scheremet R, Ostertag CB. Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 1993;78: 762-6. (Pubitemid 23121918)
7. Shapiro WR, Green SB, Burger PC, Mahaley MS, Selker RG, VanGilder JC et al. Randomized trial of the chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma: Brain Tumor Cooperative Group trial 8001. J Neurosurg 1989;71:1-9.
8. Jeremic B, Milicic B, Grujicic D, Dagovic A, Aleksandrovic J. Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach. J Cancer Res Clin Oncol 2003;129:477-84.
9. Nelson DF, Diener-West M, Weintein AS, Schoenfeld D, Nelson JS, Sause WT et al. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report on RTOG study. Int J Radiat Oncol Biol Phys 1986;12:1793-800. (Pubitemid 17182219)
10. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 1993;26:239-44.
11. Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S et al. Comparison of postoperative radiotherapy and chemotherapy in the multidisciplinary management of malign gliomas. Cancer 1983;52:997-1007.
12. Salminen E, Nuutinen JM, Huhtala S. Multivariate analysis of prognostic factors in 106 patients with malignant glioma. Eur J Cancer 1996;32(A): 1918-23.
13. Curran WJ, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993;85:704-10.
14. Ammirati M, Galicich JH, Arbit E, Liao Y. Experimental and clinical studies; Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurg 1987;21:607-14.
15. Kreth FW, Bertis A, Shiropoulou V, Faist M, Scheremet R, Rossner R et al. The role of tumor resection in the treatment of glioblastoma multiforme in adults. Cancer 1999;86:2117-23.
16. Shinoda J, Sakai N, Murase S, Yano H, Matsuhisa T, Funakoshi T. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection. J Neurooncol 2001;52:161-71.
17. Medical Research Council Brain Tumor Working Party. Prognostic factors for high grade gliomas: development of a prognostic index. J Neurooncol 1990;9:47-55.
18. Hulshof MCCM, Schimmel EC, Bosch AD, González GD. Hypofractionation in glioblastoma multiforme. Radiother Oncol 2000;54:143-8.
19. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F et al. A multivariate analysis of 416 patients with glioblastoma multiforme. J Neurosurg 2001;95:190-8.
20. Laws ER, Taylor WF, Clifton MB, Okazaki H. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg 1986;61:665-73.
21. Morantz RA. Low grade astrocytomas. In: Kaye AH, Laws Jr ER, editors. Brain tumors. 2nd ed. New York, NY: Churchill Livingstone Press; 2001. p. 467-89.
22. Oghaki H, Schäuble B, zur Hauser A, von Ammon K, Kleihues P. Genetic alterations associated with the evolution and proggresion of astrocytic brain tumors. Virchows Arch 1995;427: 113-8.
23. Leibel SA, Scott CB, Pajak TF. The management of malignant gliomas with radiation therapy: Therapeutic results and research strategies. Semin Radiat Oncol 1991;1:32-49.
24. Yilmazlar S, Aksoy K. Yuksek gradeli hemisferik glial tumorler. Turkiye Klinikleri J Neur 2004;2(S):24-9.
25. Jansen EP, Dewit LG, van Herk M, Bartelink H. Target volumes in radiotherapy for high-grade malignant glioma of the brain. Radiother Oncol 2000;56:151-6. (Pubitemid 30601671)
26. Kleinberg L, Wallner K, Malkin MG. Good performance status of long-term disease-free survivors of intracranial gliomas. Int J Radiat Oncol Biol Phys 1993;26:129-33. (Pubitemid 23137898)
27. Reni M, Cozzarini C, Ferreri AJ, Ceresoli GL, Galli L, Bianchi A et al. A retrospective analysis of postradiation chemotherapy in 133 paients with glioblastoma multiforme. Cancer Invest 2000;18:510-5.
28. Laperriere N, Zuraw L, Cairncross G, Cancer Care Ontario Practice Guidelines Initiative Neuro-Oncology Disease Site Group. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 2002;64:259-73.
29. Prados MD, Wara WM, Sneed PK, McDermott M, Chang SM, Rabbitt J et al. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standart fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2001;49:71-7.
30. Kramer S. Radiation therapy in the management of malignant gliomas. In: Cancer of the Central Nervous System. Proceedings of the Seventh National Cancer Conference. Philadelphia, PA: JB Lippincott; 1988. p. 823-6.
31. Salcman M. Glioblastoma multiforme and anaplastic astrocytoma. In: Kaye AH, Laws Jr ER, editors. Brain tumors. 2nd ed. . New York, NY: Churchill Livingstone Press; 2001. p. 493-519.
32. Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Brooks WH et al. A randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980;303:1323-9.
33. Jaeckle KA, Eyre HJ, Townsend JJ, Schulman S, Knudson HM, Belanich M et al. Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis- chloroethylnitrosourea: a Southwest Oncology Group study. J Clin Oncol 1998;16:3310-5.
34. Walker MD, Alexander E, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr et al. Evalation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: A cooperative clinical trial. J Neurosurg 1988;49:333-43.
35. van Rijn J, Heimans JJ, van den Berg J, van der Valk P, Slotman BJ. Survival of human glioma cells treated with various combination of temozolomide and x-rays. Int J Radiat Oncol Biol Phys 2000;47:779-84.
36. Athanassiou H, Synodinou M, Maragoudakis E, Pareskevaidis M, Verigos C, Misailidou D et al. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. J Clin Oncol 2005;23: 2372-7.
37. Stupp R, Mason WP, Van Den Bent MJ, Weiler M, Fisher B, Taphoorn MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96.
38. Kocher M, Kunze S, Eich HT, Semrau R, Muller RP. Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma. Strahlenther Onkol 2005;181:157-63. (Pubitemid 40500898)
39. Combs SE, Gutwein S, Schulz-Ertner D, van Kampen M, Thilmann C, Edler L et al. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study. Strahlenther Onkol 2005;181:372-7.
40. Barker FG II, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD et al. Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 1998;42:709-23.
41. Stenning SP, Freedman LS, Bleehen NM. Prognostic factors for high-grade malignant glioma: development of a prognostic index. J Neurooncol 1990;9:47-55.
42. Roth JG, Elvidge AR. Glioblastoma multiforme: a clinical survey. J Neurosurg 1960;17:736-50.
43. Young B, Oldfield EH, Markesbery WR, Haack D, Tibbs PA, McCombs P et al. Reoperation for glioblastoma. J Neurosurg 1981;55:917-21.
44. Harsh GR IV, Levin VA, Gutin PH, Seager M, Silver P, Wilson CB. Reoperation for recurrent glioblastoma and anaplastyc astrocytoma. Neurosurgery 1987;21:615-21. (Pubitemid 18001497)